{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:52:42Z","timestamp":1787061162321,"version":"build-2736575974"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    Adult-onset Still's disease (AOSD) is a systemic disorder commonly accompanied by liver involvement. This study aims to illustrate the detailed information of liver abnormalities in patients with AOSD and evaluate the impact on the prognosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    A total number of 128 hospitalized patients, who met the Yamaguchi criteria of AOSD in the Department of Rheumatology and Immunology, Ruijin Hospital from July 2016 to August 2019 were consecutively enrolled and followed up. The demographic characteristics, clinical features, laboratory tests, treatments and prognosis were recorded. Correlations of liver function tests (LFTs) with disease activity and laboratory parameters were analyzed by the Spearman test. Risk factors of the refractory AOSD were evaluated by multivariate logistic regression analysis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Liver involvement was presented in 104 (81.3%) patients with AOSD. We observed that 34 (32.7%) patients were with mild elevation, 32 (30.8%) patients were with moderate elevation, and 38 (36.5%) patients were with severe elevation. The majority of elevated ALT, AST and ALP decreased to normal within the range of 2 months, except for GGT. Furthermore, the LFTs were found significantly correlated with disease activity. Besides, we found patients with higher levels of LFTs tended to require more intensive treatments and suffered from poorer prognosis. Multivariate logistic regression analysis showed ALP \u2265 141 IU\/L and GGT \u2265 132 IU\/L are independent risk factors of refractory AOSD.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Liver involvement is common in patients with AOSD, the levels of LFTs are associated with disease activity and related to the treatment strategies and prognosis.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2020.621005","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T01:31:44Z","timestamp":1608687104000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["A Cohort Study of Liver Involvement in Patients With Adult-Onset Still's Disease: Prevalence, Characteristics and Impact on Prognosis"],"prefix":"10.3389","volume":"7","author":[{"given":"Huihui","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingyang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tienan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junna","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuochao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengde","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still's disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1097\/CM90000000000000538","article-title":"Pathogenesis, disease course, and prognosis of adult-onset Still's disease","volume":"132","author":"Wang","year":"2019","journal-title":"Chin Med J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Med (Baltimore)"},{"key":"B4","first-page":"784","article-title":"Fulminant hepatic failure in adult onset Still's disease","volume":"23","author":"Dino","year":"1996","journal-title":"J Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/j.ejim.2007.06025","article-title":"Fulminant hepatitis requiring MARS and liver transplantation in a patient with Still's disease","volume":"19","author":"Taccone","year":"2008","journal-title":"Eur J Intern Med"},{"key":"B6","first-page":"1093","article-title":"Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease","volume":"30","author":"Ogata","year":"2003","journal-title":"J Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s10067-008-0950-9","article-title":"Steroid-refractory severe hepatic failure in adult onset Still's disease responding to cyclosporine","volume":"27","author":"Nagashima","year":"2008","journal-title":"Clin Rheumatol"},{"key":"B8","first-page":"1058","article-title":"Adult Still's disease: a multicenter survey of Japanese patients","volume":"17","author":"Ohta","year":"1990","journal-title":"J Rheumatol"},{"key":"B9","first-page":"2345","article-title":"Clinical characteristics, treatment, and outcome of adult onset Still's disease in southern Chinese","volume":"25","author":"Mok","year":"1998","journal-title":"J Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3899\/jrheum080365","article-title":"Clinical features and prognosis of adult-onset Still's disease: 61 cases from China","volume":"36","author":"Zeng","year":"2009","journal-title":"J Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/RHU0b013e3181b57199","article-title":"Liver abnormalities in adult onset Still's disease: a retrospective study of 77 Chinese patients","volume":"15","author":"Zhu","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaut.2016.02010","article-title":"Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort","volume":"69","author":"Kalyoncu","year":"2016","journal-title":"J Autoimmun"},{"key":"B13","first-page":"52","article-title":"Clinical features and current treatments of adult-onset Still's disease: a multicentre survey of 517 patients in China","volume":"37","author":"Hu","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B14","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/ard.61.8718","article-title":"Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology","volume":"61","author":"Buttgereit","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/art27532","article-title":"Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease","volume":"62","author":"Franchini","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B18","first-page":"192","article-title":"Retrospective monocentric study of 17 patients with adult Still's disease, with special focus on liver abnormalities","volume":"50","author":"Andres","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1183\/09031936.9609081736","article-title":"Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation","volume":"9","author":"Drent","year":"1996","journal-title":"Eur Respir J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/hep22716","article-title":"Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells","volume":"49","author":"Ruddell","year":"2009","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Rosario","year":"2013","journal-title":"BMC Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clim.2009.02005","article-title":"Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin","volume":"132","author":"Coca","year":"2009","journal-title":"Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00277-017-2993-y","article-title":"Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review","volume":"96","author":"Lin","year":"2017","journal-title":"Ann Hematol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1007\/s10067-019-04642-x","article-title":"Elevated serum levels of interleukin-10 in adult-onset Still's disease are associated with disease activity","volume":"38","author":"Sun","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/rheumatology\/keq397","article-title":"Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis","volume":"50","author":"Priori","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3899\/jrheum130575","article-title":"Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis","volume":"41","author":"Priori","year":"2014","journal-title":"J Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1136\/annrheumdis-2018-eular6246","article-title":"Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still's disease","volume":"77","author":"Kim","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/ard.2005047621","article-title":"Successful treatment of refractory adult onset Still's disease with rituximab","volume":"65","author":"Ahmadi-Simab","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jada.2004.05213","article-title":"Hepatic proteins and nutrition assessment","volume":"104","author":"Fuhrman","year":"2004","journal-title":"J Am Diet Assoc"},{"key":"B31","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.amjmed.2019.10.031","article-title":"Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study","volume":"133","author":"Eckart","year":"2019","journal-title":"Am J Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1432-1033.1982.tb07051x","article-title":"Metabolism of prealbumin in rats and changes induced by acute inflammation","volume":"129","author":"Dickson","year":"1982","journal-title":"Eur J Biochem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/BF02201003","article-title":"Caeruloplasmin, prealbumin and alpha 2-macroglobulin as potential indices of disease activity in different arthritides","volume":"6","author":"Surrall","year":"1987","journal-title":"Clin Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.nut.2012.02009","article-title":"Nutritional status in relation to adipokines and oxidative stress is associated with disease activity in patients with rheumatoid arthritis","volume":"28","author":"Hayashi","year":"2012","journal-title":"Nutrition"},{"key":"B35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/rheumatology\/kev322","article-title":"Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients","volume":"55","author":"Codullo","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejim.2018.04014","article-title":"Human serum albumin in cardiovascular diseases","volume":"52","author":"Arques","year":"2018","journal-title":"Eur J Intern Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2215\/CJN10441015","article-title":"Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD","volume":"11","author":"Sun","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1046\/j.1523-1755.2000.00435x","article-title":"Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients","volume":"58","author":"Chertow","year":"2000","journal-title":"Kidney Int"},{"key":"B39","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3899\/jrheum170955","article-title":"Macrophage activation syndrome in patients affected by adult-onset still disease: analysis of survival rates and predictive factors in the gruppo Italiano di ricerca in reumatologia clinica e sperimentale cohort","volume":"45","author":"Ruscitti","year":"2018","journal-title":"J Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13054-018-2012-2","article-title":"Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review","volume":"22","author":"N\u00e9el","year":"2018","journal-title":"Crit Care"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1136\/annrheumdis-2019-215211","article-title":"Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"78","author":"Minoia","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gut.35.4569","article-title":"Fulminant hepatic failure secondary to hydroxychloroquine","volume":"35","author":"Makin","year":"1994","journal-title":"Gut"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.autrev.2014.08027","article-title":"Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients","volume":"13","author":"Kivity","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/annrheumdis-2019-216653","article-title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"79","author":"Sepriano","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/ard.56.2144","article-title":"Methotrexate treatment in patients with adult onset Still's disease\u2013retrospective study of 13 Japanese cases","volume":"56","author":"Fujii","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fphar.201700369","article-title":"Response to interleukin-1 inhibitors in 140 Italian patients with Adult-Onset Still's Disease: a multicentre retrospective observational study","volume":"8","author":"Colafrancesco","year":"2017","journal-title":"Front Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/annrheumdis-2017-212608","article-title":"Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease","volume":"77","author":"Gabay","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1136\/annrheumdis-2018-213920","article-title":"Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial","volume":"77","author":"Kaneko","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/annrheumdis-2019-216699","article-title":"Tofacitinib in refractory adult-onset Still's disease: 14 cases from a single centre in China","volume":"79","author":"Hu","year":"2020","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.621005\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T01:31:49Z","timestamp":1608687109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.621005\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,23]]},"references-count":49,"alternative-id":["10.3389\/fmed.2020.621005"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.621005","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,23]]},"article-number":"621005"}}